The world renowned Israeli Biomed Conference hosts representatives of leading companies, senior lecturers and hundreds of guests involved in the life sciences from Israel and around the world every year. The events of Israel Biomed Week enable Israeli companies to create business ties and opportunities and to maximize exposure for their most innovative products and developments.

As part of the effort to showcase Israeli companies to the Chinese market, a number of important delegations from China arrived this week to the conference as guests of the Israel Innovation Authority. Unique among these is a delegation of investment bodies (both private and funds) with diverse fields of interest including life sciences, IT and cleantech. In addition, some 20 Chinese companies in the fields of medical equipment, pharmaceuticals and agricultural technology from the provinces of Sichuan, Shandong and Zhejiang sent representatives to the conference. The arrival of these delegations is a result of the close cooperation between the Israel Innovation Authority, Chinese provincial governments and the federal Ministry of Science and Technology of the People’s Republic of the China.

In a unique event sponsored by the Israel Innovation Authority in Tel Aviv, some 500 B2B meetings took place, aimed at forging business ties between Chinese and Israeli companies and at encouraging Chinese investment in Israeli companies. The meetings, scheduled in advance, are an important platform for creating business cooperation, investments, research and development and more. They also help Israeli companies maximize their exposure in the Chinese market. Among the leading investment agencies in attendance: PingAn, Biossom Investment Co and Chengdo Kanghong Pharmaceutical Group, owner of seven Chinese pharmaceutical companies. Each of these investment bodies manages investments totaling c. $500 million.

Ahead of the unique Chinese-Israeli meetings, the Chairman of the Israel Innovation Authority, Mr. Avi Hasson, spoke about the future of Israel’s biomed industry.

Avi Luvton, Asia Pacific Director at the Israel Innovation Authority, said: “The arrival of the investor delegation is especially important and aims at creating meetings between Israeli companies and potential Chinese investors. The group of high quality investors invited to the B2B meeting event was carefully selected to create real opportunities for cooperation with the Israeli companies taking part in the event. We were happy to see that there was great demand on the side of Israeli companies and we did our best to enable as large a number of Israeli companies as possible to take part in this unique event.”

The 15th annual Israel Biomed Conference is an international conference with the participation of life science and technology companies from around the world. The conference is organized by the Israel Advanced Technology Industries (IATI), an umbrella organization of the hi-tech and life science industries, and Kenes Exhibitions, a company specializing in conference productions. The conference was attended by Israel Innovation Authority Chairman and Chief Scientist Avi Hasson and GM, Early Stage Companies and Incubators at the Israel Innovation Authority, Anya Eldan.

(YWN – Israel Desk, Jerusalem)